2024
Mediation Analysis of Acute Carotid Stenting in Tandem Lesions
Rodriguez Calienes A, Galecio-Castillo M, Petersen N, Ribo M, Farooqui M, Hassan A, Jumaa M, Divani A, Abraham M, Fifi J, Guerrero W, Malik A, Siegler J, Nguyen T, Sheth S, Yoo A, Linares G, Janjua N, Quispe-Orozco D, Lu Y, Vivanco-Suarez J, Dibas M, Mokin M, Yavagal D, Jovin T, Ortega-Gutierrez S. Mediation Analysis of Acute Carotid Stenting in Tandem Lesions. Neurology 2024, 103: e209617. PMID: 38959444, DOI: 10.1212/wnl.0000000000209617.Peer-Reviewed Original ResearchConceptsAcute carotid artery stentingCarotid artery stentingEndovascular therapyNon-CA groupFunctional outcomesTandem lesionsAnterior circulation tandem lesionsTreated with endovascular therapyMulticenter retrospective cohort studyCarotid artery stenting groupAssociated with better functional outcomesFavorable functional outcomeAcute carotid stentingRetrospective cohort studyAssociated with functional outcomePredictor of functional outcomeCervical lesionsMedian ageModified ThrombolysisReperfusion rateCohort studyPathophysiological mechanismsArtery stentingCarotid stentingReperfusionAssociation of Acute Carotid Stenting with Functional Outcome Mediated by Successful Reperfusion in Tandem Lesions: Mediation Analysis of a Multicenter Registry (P2-5.006)
Rodriguez-Calienes A, Galecio-Castillo M, Hassan A, Jumaa M, Divani A, Ribo M, Abraham M, Petersen N, Fifi J, Guerrero W, Malik A, Siegler J, Nguyen T, Sheth S, Yoo A, Linares G, Janjua N, Quispe-Orozco D, Lu Y, Vivanco-Suarez J, Dibas M, Mokin M, Yavagal D, Ortega-Gutierrez S. Association of Acute Carotid Stenting with Functional Outcome Mediated by Successful Reperfusion in Tandem Lesions: Mediation Analysis of a Multicenter Registry (P2-5.006). Neurology 2024, 102 DOI: 10.1212/wnl.0000000000206545.Peer-Reviewed Original Research
2023
Low dose intravenous cangrelor versus glycoprotein IIb/IIIa inhibitors in endovascular treatment of tandem lesions
Jumaa M, Rodriguez-Calienes A, Dawod G, Vivanco-Suarez J, Hassan A, Divani A, Oliver M, Ribo M, Petersen N, Abraham M, Fifi J, Guerrero W, Malik A, Siegler J, Nguyen T, Sheth S, Yoo A, Linares G, Janjua N, Quispe-Orozco D, Galecio-Castillo M, Zevallos C, Malaga M, Farooqui M, Jovin T, Zaidi S, Ortega-Gutierrez S. Low dose intravenous cangrelor versus glycoprotein IIb/IIIa inhibitors in endovascular treatment of tandem lesions. Journal Of Stroke And Cerebrovascular Diseases 2023, 32: 107438. PMID: 37883826, PMCID: PMC11271813, DOI: 10.1016/j.jstrokecerebrovasdis.2023.107438.Peer-Reviewed Original ResearchConceptsSymptomatic intracranial hemorrhageGP IIb/IIIa inhibitorsRate of symptomatic intracranial hemorrhageGP IIb/IIIaAntiplatelet therapyMechanical thrombectomyRetrospective non-randomized cohort studyGP IIb/IIIa inhibitor groupHemorrhagic infarction type 1Tandem lesionsComplete reperfusionType 1Periprocedural antiplatelet therapyReducing hemorrhage ratesParenchymal hematoma type 1Treatment of tandem lesionsNon-randomized cohort studyAcute carotid stentingIntravenous (IVGlycoprotein IIb/IIIa inhibitorsRate of complete reperfusionAssociated with increased oddsCangrelor groupHemorrhage rateIntravenous cangrelor
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply